Sandoz Group (OTCMKTS:SDZNY) Shares Gap Down – What’s Next?

Sandoz Group AG Sponsored ADR (OTCMKTS:SDZNY) shares gapped down before the market opened on Wednesday . The stock had previously closed at $83.75, but opened at $79.84. Sandoz Group shares last traded at $79.91, with a volume of 6,076 shares traded.

Analysts Set New Price Targets

Separately, Barclays upgraded Sandoz Group to a “strong-buy” rating in a research note on Monday, October 13th. One equities research analyst has rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Sandoz Group Stock Performance

The company has a current ratio of 1.29, a quick ratio of 0.82 and a debt-to-equity ratio of 0.62. The company has a fifty day simple moving average of $73.62 and a two-hundred day simple moving average of $65.53.

About Sandoz Group

Sandoz Group (OTCMKTS:SDZNY) is a multinational pharmaceutical company focused on the development, manufacturing and commercialization of generic medicines and biosimilars. The company supplies off-patent small-molecule drugs as well as biologic alternatives intended to offer lower-cost therapeutic options across a range of clinical areas. Sandoz emphasizes access and affordability, positioning its portfolio to serve hospitals, pharmacies and health systems looking to expand patient access to essential therapies.

The company’s product offerings span conventional generics, complex and specialty generics, and a growing pipeline of biosimilar medicines.